Population pharmacodynamic model for ketorolac analgesia

Clinical Pharmacology and Therapeutics

Volumn 60, Issue 6, 1996, Pages 619-635

  Mandema, Jaap W ^a,b   Stanski, Donald R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALZA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETOROLAC;

ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG HALF LIFE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PHARMACOKINETICS; POPULATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; THEORETICAL STUDY;

ADMINISTRATION, ORAL; ANALGESICS, NON-NARCOTIC; HUMANS; INJECTIONS, INTRAMUSCULAR; KETOROLAC; MODELS, THEORETICAL; MONTE CARLO METHOD; PAIN, POSTOPERATIVE; TIME FACTORS; TOLMETIN;

EID: 0030471388     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90210-6     Document Type: Article

References (19)

1. Buckley MMT, Brogden RN. Ketorolac: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1990;39:86-109.
2. Young JM, Yee JP. Ketorolac. In: Lewis AJ, Furst DE, editors. Nonsteroidal anti-inflammatory drugs: mechanisms and clinical uses. 2nd ed. New York: Marcel Dekker, 1994:247-66.
3. Max, MB, Portenoy RK, Laska EM, editors. Advances in pain research and therapy; vol 18: the design of analgesic clinical trials. New York: Raven Press, 1991.
4. Laska EM, Siegel C, Sunshine A. Onset and duration: measurement and analysis. Clin Pharmacol Ther 1991;49:1-5.
5. Sheiner LB. A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data. Clin Pharmacol Ther 1994;56:309-22.
6. Sheiner LB, Beal SL, Dunne A. Analysis of non-randomly censored ordered categorical longitudinal data from analgesic trials. J Am Stat Assoc [in press].
7. Hastie TJ, Botha JL, Schnitzler CM. Regression with an ordered categorical response. Stat Med 1989;8: 785-94.
8. Velagapudi R, Harter JG, Brueckner R, Peck CC. Pharmacokinetic/pharmacodynamic models in analgesic study design. In: Max MB, Portenoy RK, Laska EM, editors. Advances in pain research and therapy, vol 18, New York: Raven Press, 1991:559-62.
9. Wajdula JS, Vavra I, Sullivan D, Ermer J, Osman M. Bromfenac. In: Lewis AJ, Furst DE, editors. Nonsteroidal anti-inflammatory drugs: mechanisms and clinical uses. 2nd ed. New York: Marcel Dekker, 1994: 267-84.
10. Sheiner LB. Population approach in drug development: rationale and basic concepts. In: Roland M, Aarons L, editors. New strategies in drug development and clinical evaluation: the population approach. Luxembourg: Commission of the European Communities, 1992:13-29.
11. O'Hara DA, Fragen RJ, Kinzer M, Pemberton D. Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative pain. Clin Pharmacol Ther 1987;41:556-61.
12. Mroszczak EJ, Jung D, Yee J, Bynum L, Sevelius H, Massey I. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. Pharmacotherapy 1990;10:33S-9S.
13. Stanski DR, Cherry C, Bradley R, Sarnquist FH, Yee JP. Efficacy and safety of single doses of intramuscular ketorolac tromethamine compared with meperidine for postoperative pain. Pharmacotherapy 1990;10: 40S-4S.
14. Brown CR, Moodie JE, Dickie G, Wild VM, Smith BA, Clarke PJ, et al. Analgesic efficacy and safety of single-dose oral and intramuscular ketorolac tromethamine for postoperative pain. Pharmacotherapy 1990;10:59S-70S.
15. Brown CR, Moodie JE, Phillips E, Jung D, McHugh DP, Mroszczak EJ, et al. Pharmacokinetics and pharmacodynamics (PK/PD) of ketorolac tromethamine (KT) IM and IV following major orthopedic surgery [abstract]. Clin Pharmacol Ther 1993;53:222.
16. Beal SL, Sheiner LB. Estimating population kinetics. Crit Rev Biomed Eng 1982;8:195-222.
17. Beal SL, Sheiner LB. NONMEM users guides, part I-VII. San Francisco: University of California, 1992.
18. McCullagh P, Neider JA. Generalized linear models. 2nd ed. New York: Chapman & Hall, 1989.
19. Brocks DR, Jamali F. Clinical pharmacokinetics of ketorolac tromethamine. Clin Pharmacokinet 1992; 23:415-27.